Recent advances in therapeutic approaches for adult T-cell leukemia/lymphoma

研究成果: Contribution to journalReview article

25 引用 (Scopus)

抜粋

Adult T-cell leukemia/lymphoma (ATLL) is a peripheral T-cell lymphoma caused by human T-cell leukemia/lymphoma virus type 1 (HTLV-1). ATLL occurs in approximately 3%–5% of HTLV-1 carriers during their lifetime and follows a heterogeneous clinical course. The Shimoyama classification has been frequently used for treatment decisions in ATLL patients, and antiviral therapy has been reportedly promising, particularly in patients with indolent type ATLL; however, the prognosis continues to be dismal for patients with aggressive-type ATLL. Recent efforts to improve treatment outcomes have been focused on the development of prognostic stratification and improved dosage, timing, and combination of therapeutic modalities, such as antiviral therapy, chemotherapy, allogeneic hematopoietic stem cell transplantation, and molecular targeted therapy.

元の言語英語
ページ(範囲)6604-6612
ページ数9
ジャーナルViruses
7
発行部数12
DOI
出版物ステータス出版済み - 12 14 2015

All Science Journal Classification (ASJC) codes

  • Infectious Diseases
  • Virology

フィンガープリント Recent advances in therapeutic approaches for adult T-cell leukemia/lymphoma' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用